Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:44 p.m.

    📋 Scholar Rock Holding Corp (SRRK) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 09:23:39

    Event Type: Clinical Trial Update

    Event Details:

    Scholar Rock Holding Corp (SRRK) Announces Clinical Trial Update Scholar Rock Holding Corp (SRRK) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: year, cleared
    • Diseases/Conditions: facioscapulohumeral muscular dystrophy (FSHD), spinal
    • Clinical Stage: Phase 1 study, Phase 2
    • Collaboration: IND
    • Updated Timeline: December 31, 2025
      • expected in H2 2026
      • anticipated in 2026
      • expected in the second half of 2026

    🔬 Clinical Development Pipeline (Scholar Rock Holding Corp):

    Product Type Development Stage Therapeutic Area Source
    anti-PD-(L)1 antibody therapy BIOLOGICAL Phase PHASE1 Cancer ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Overweight and Obesity ClinicalTrials.gov
    Risdiplam DRUG Phase PHASE2 Spinal Muscular Atrophy ClinicalTrials.gov
    Nusinersen DRUG Phase PHASE2 Spinal Muscular Atrophy ClinicalTrials.gov
    Apitegromab DRUG Phase PHASE2 Spinal Muscular Atrophy ClinicalTrials.gov
    Tirzepatide DRUG Phase PHASE2 Overweight and Obesity ClinicalTrials.gov
    SRK-181 BIOLOGICAL Phase PHASE1 Cancer ClinicalTrials.gov
    SRK-015 BIOLOGICAL Phase PHASE2 Spinal Muscular Atrophy ClinicalTrials.gov
    Optimized rehabilitation program OTHER Approved Spinal Muscular Atrophy ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Scholar Rock Holding Corp
    • Ticker Symbol: SRRK

Search

News categories